We understand the enormous complexity of developing biologic therapeutics because we've been there. Our hands-on experience encompasses the development, manufacturing, regulation and commercialization of innovator biotherapeutic products.

We're expanding access to quality care by reinventing the business of biopharmaceuticals.

Coherus has redefined innovation to mean reinventing the biotech business model. We're about collaboration not control, efficiency not ownership and processes that are both smarter and faster. The goal is to increase speed-to-market while decreasing costs for safe, high quality biotherapeutics.

The New Model: To be successful in the rapidly emerging biosimilars market and expand access to lifesaving drugs.

Specialized knowledge is required to create, manufacture and develop complex biosimilar therapies in regulated markets where the technical hurdles are high. Expertise in both molecular biology and commercial biomanufacturing is essential and is part of Coherus's core capabilities.

Expertise in molecular biology and commercial biomanufacturing are an essential part of our core capabilities.

The Coherus Mission

Coherus Biosciences is dedicated to providing patients around the world with greater access to high-quality biosimilar therapies.

Learn More

The New Model

To be successful in the rapidly emerging biosimilars market and expand access to lifesaving drugs, we need to build on the best of the past, innovate entirely new ways of thinking and throw open the door to real competition.

Learn More